Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva sues Apotex for Azilect patent infringement
Globes, Israel
Monday, June 13, 2011 - 10:10am
tags:
Teva Pharmaceuticals, patents, Azilect, Apotex, Parkinson's Disease
Synageva snags troubled Trimeris, goes public in M&A deal
Fierce Biotech
Monday, June 13, 2011 - 10:08am
tags:
Synageva, Trimeris, M&A
Vertex Pharma licenses 2 oral hepatitis C drug candidates from Alios BioPharma
Yahoo/AP
Monday, June 13, 2011 - 10:06am
tags:
Vertex Pharmaceuticals, Allos, hepatitis C
The Data Economy: How Social Networking Is Changing the Health Care Industry
Minyanville
Monday, June 13, 2011 - 10:06am
tags:
social media
Icahn nominates 4 candidates to Forest Labs board
Yahoo/AP
Monday, June 13, 2011 - 9:20am
tags:
Carl Icahn, Forest Labs
Why A Boehringer Unit Really Has Drug Shortages
Pharmalot
Monday, June 13, 2011 - 9:19am
tags:
drug shortages, Boehringer Ingelheim
Pfizer Looks to Extend Viagra Patent to 2019
WSJ Online
Monday, June 13, 2011 - 9:09am
tags:
Viagra, Pfizer, patents, erectile dysfunction
High copays blamed as 1 in 6 Medicare recipients don't fill prescriptions for new cancer drugs
Yahoo/AP
Monday, June 13, 2011 - 8:26am
tags:
cancer, Medicare
Glaxo-Valeant seizure treatment cleared by U.S.
Marketwatch
Monday, June 13, 2011 - 8:26am
tags:
GSK, Valeant Pharmaceuticals, FDA, partial seizures, Potiga
7 Pharmaceuticals Awaiting FDA Decisions This Week
Seeking Alpha
Sunday, June 12, 2011 - 11:12am
tags:
GSK, Valeant Pharmaceuticals, Bristol-Myers Squibb, Acura Pharmaceuticals, Regeneron, Bayer
Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
Benzinga
Sunday, June 12, 2011 - 11:09am
tags:
Soliris, Alexion, atypical hemolytic uremic syndrome
USFDA restricts sale of cholesterol-lowering drug Simvastatin
Business Standard, India
Sunday, June 12, 2011 - 10:59am
tags:
Simvastatin, Zocor, cholesterol
Plasticizer Levels Prompt Hong Kong to Yank GSK Drug
Motley Fool
Sunday, June 12, 2011 - 10:47am
tags:
GSK
As the Market Dips, It's Time to Look for Biotech Sector Deals
Seeking Alpha
Sunday, June 12, 2011 - 10:45am
tags:
Amarin, Dendreon, Titan, Avanir, Celldex, CytRx, MannKind
Top 2 Pharmaceutical Stocks: Teva More Stable, Vanda Has Larger Upside
Seeking Alpha
Sunday, June 12, 2011 - 10:43am
tags:
Teva Pharmaceuticals, Vanda
Incyte Reports Additional Analyses of Symptomatic Improvement and Quality of Life with Ruxolitinib (INC424) in Patients with Myelofibrosis from the COMFORT-I Study
BusinessWire
Sunday, June 12, 2011 - 10:36am
tags:
Incyte, ruxolitinib, myelofibrosis
Some Crucial Cancer Medicine In Short Supply
Connecticut Watchdog, CT
Saturday, June 11, 2011 - 2:42pm
tags:
generics, oncology
Elder Pharma to launch 35 products in 30 months
Business Standard, India
Saturday, June 11, 2011 - 2:38pm
tags:
Elder Pharmaceuticals
Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets
MedIndia, India
Saturday, June 11, 2011 - 2:36pm
tags:
Aurobindo, ramipril, generics
Eli Lilly insulin brand paves way for hike in imported drug prices (in India)
Economic Times, India
Saturday, June 11, 2011 - 12:29pm
tags:
Eli Lilly, insulin, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.